Trace Neuroscience: Funding, Investors & Team (Sep 2026)
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
Trace Neuroscience has raised $101M across 1 funding round on record, the most recent a Series A of $101M announced in Nov 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Trace Neuroscience Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Trace Neuroscience Funding Rounds
Trace Neuroscience Founders and Leadership Team
No contact details are on record for this team yet.
Trace Neuroscience Funding Compared to Other Biotechnology Startups
Trace Neuroscience's latest round of $101M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Trace Neuroscience in Biotechnology and South San Francisco
Companies Similar to Trace Neuroscience
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Trace Neuroscience Funding FAQs
What does Trace Neuroscience do?
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
How much funding has Trace Neuroscience raised?
Trace Neuroscience has raised $101M across 1 round on record. The most recent is a Series A of $101M announced in Nov 2024.
When did Trace Neuroscience last raise funding?
Trace Neuroscience's most recent funding round on record is a Series A of $101M, announced in Nov 2024.
Who founded Trace Neuroscience?
FundedIQ lists Eric Green (Founder) at Trace Neuroscience.
Where is Trace Neuroscience headquartered?
Trace Neuroscience is based in South San Francisco, California, United States.
How many employees does Trace Neuroscience have?
Trace Neuroscience is in the 11-50 employee band.
How does Trace Neuroscience's funding compare to other Biotechnology startups?
Trace Neuroscience's latest round of $101M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Trace Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Trace Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.